CROSS COUNTRY HEALTHCARE INC
CROSS COUNTRY HEALTHCARE INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 106 | 109 | 99 | 81 | 81 | 82 | 64 | 70 | 5 | 17 | 14 | 1 | |||||
Accounts Receivable Net Current | 177 | 168 | 180 | 202 | 220 | 223 | 245 | 242 | 357 | 372 | 410 | 485 | |||||
Income Taxes Receivable | 3 | 4 | 4 | 5 | 6 | 10 | 10 | 9 | 6 | 9 | 5 | 4 | |||||
Prepaid Expense Current | 7 | 8 | 5 | 8 | 8 | 8 | 5 | 6 | 8 | 8 | 5 | 7 | |||||
Insurance Settlements Receivable Current | 4 | 5 | 6 | 11 | 9 | 9 | 12 | 9 | 9 | 9 | 8 | 8 | |||||
Other Assets Current | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 2 | 2 | 3 | 1 | |||||
Assets Current | 298 | 294 | 295 | 309 | 325 | 335 | 337 | 338 | 387 | 417 | 445 | 506 | |||||
Property Plant And Equipment Net | 27 | 28 | 28 | 28 | 28 | 29 | 29 | 29 | 28 | 27 | 26 | 25 | |||||
Operating Lease Right Of Use Asset | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 2 | |||||
Goodwill | 64 | 64 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 137 | |||||
Intangible Assets Net Excluding Goodwill | 26 | 28 | 36 | 38 | 40 | 42 | 46 | 49 | 52 | 54 | 57 | 60 | |||||
Deferred Income Tax Assets Net | - | 0 | 9 | 8 | 9 | 8 | 9 | 10 | 7 | 6 | 7 | 8 | |||||
Insurance Settlements Receivable Noncurrent | 14 | 15 | 15 | 16 | 20 | 21 | 22 | 23 | 23 | 26 | 22 | 22 | |||||
Deferred Compensation Plan Assets | 3 | 3 | - | - | - | 3 | - | - | - | - | - | - | |||||
Other Assets Noncurrent | 2 | 2 | 5 | 5 | 5 | 3 | 7 | 7 | 7 | 7 | 7 | 12 | |||||
Assets | 451 | 449 | 538 | 554 | 576 | 589 | 597 | 603 | 648 | 681 | 708 | 771 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable And Other Accrued Liabilities Cur… | 48 | 46 | 42 | 49 | 56 | 65 | 58 | 56 | 69 | 93 | 115 | 140 | |||||
Employee Related Liabilities Current | 40 | 28 | 42 | 45 | 50 | 48 | 54 | 47 | 52 | 52 | 57 | 56 | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | |||||
Business Combination Contingent Consideration Liab… | - | 0 | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 7 | 7 | 16 | |||||
Other Liabilities Current | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 1 | |||||
Liabilities Current | 91 | 78 | 86 | 96 | 109 | 120 | 121 | 110 | 128 | 156 | 184 | 216 | |||||
Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | |||||
Other Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 31 | |||||
Deferred Income Tax Liabilities Net | 3 | 3 | - | - | - | 1 | - | - | - | - | - | - | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | 0 | 0 | 0 | 0 | 5 | 5 | 5 | |||||
Liability For Claims And Claims Adjustment Expense | 30 | 30 | 29 | 30 | 34 | 34 | 35 | 36 | 34 | 35 | 33 | 32 | |||||
Liability For Uncertain Tax Positions Noncurrent | 11 | 10 | 10 | 10 | 10 | 10 | 11 | 12 | 11 | 11 | 10 | 9 | |||||
Deferred Compensation Liability Classified Noncurr… | 2 | 3 | - | - | - | 3 | - | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 1 | 2 | 4 | 3 | 3 | 0 | 4 | 4 | 4 | 4 | 4 | 4 | |||||
Liabilities | 138 | 126 | 130 | 142 | 158 | 170 | 173 | 164 | 180 | 213 | 238 | 301 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 196 | 201 | 204 | 203 | 202 | 202 | 204 | 215 | 229 | 236 | 242 | 255 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -2 | -2 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |||||
Retained Earnings Accumulated Deficit | 119 | 123 | 206 | 211 | 218 | 218 | 222 | 225 | 241 | 233 | 229 | 217 | |||||
Stockholders Equity | 313 | 323 | 408 | 412 | 418 | 419 | 425 | 433 | 462 | 468 | 464 | 470 | |||||
Liabilities And Stockholders Equity | 451 | 449 | 538 | 554 | 576 | 589 | 597 | 603 | 648 | 681 | 708 | 771 | |||||
Allowance For Doubtful Accounts Receivable Current | 9 | 9 | 9 | 10 | 10 | 9 | 35 | 36 | 20 | 21 | 20 | 19 | |||||
Common Stock Par Or Stated Value Per Share | - | 0 | - | - | - | 0 | - | - | - | 0 | - | - | |||||
Common Stock Shares Authorized | - | 100 | - | - | - | 100 | - | - | - | 100 | - | - | |||||
Common Stock Shares Issued | - | 32 | - | - | - | 32 | - | - | - | 34 | - | - | |||||
Shares Outstanding | - | 32 | - | - | - | 32 | - | - | - | 34 | - | - | |||||
Accumulated Depreciation Depletion And Amortizatio… | 28 | - | 26 | 24 | 22 | - | 21 | 19 | 17 | - | 20 | 20 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.72% | 0.30% | 0.53% | - | - | - | - | - | - | - | - | - |
| 2025 | -4.77% | -7.59% | -1.73% | 2.14% | 8.63% | -1.07% | -36.76% | -36.28% | -26.32% | -8.84% | 1.59% | 29.94% |
| 2024 | -13.38% | -16.61% | -8.96% | -12.59% | -17.21% | -26.67% | -12.31% | 46.70% | 48.33% | -11.03% | -18.45% | -19.81% |
| 2023 | - | - | - | 13.14% | 10.64% | 2.64% | 4.97% | 13.56% | 10.60% | 0.76% | 3.29% | -12.18% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.29 | 3.78 | 3.45 | 3.21 | 2.98 | 2.78 | 2.79 | 3.07 | 3.02 | 2.67 | 2.43 | 2.34 | |||||
| Quick Ratio | 3.21 | 3.68 | 3.39 | 3.13 | 2.91 | 2.72 | 2.75 | 3.01 | 2.96 | 2.62 | 2.40 | 2.31 | |||||
| Working Capital | 207.73M | 215.83M | 209.57M | 212.89M | 216.15M | 214.60M | 215.91M | 227.64M | 258.88M | 260.80M | 261.65M | 289.61M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.44 | 0.39 | 0.32 | 0.34 | 0.38 | 0.41 | 0.41 | 0.38 | 0.39 | 0.45 | 0.51 | 0.64 | |||||
| Interest Coverage TTM | -39.10 | -38.09 | -7.20 | -3.30 | -9.15 | -7.71 | -0.00 | 7.63 | 14.76 | 13.93 | 13.68 | 13.18 | |||||
| Debt Ratio | 0.31 | 0.28 | 0.24 | 0.26 | 0.27 | 0.29 | 0.29 | 0.27 | 0.28 | 0.31 | 0.34 | 0.39 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.95 | 2.03 | 1.99 | 2.06 | 2.05 | 2.12 | 2.22 | 2.29 | 2.26 | 2.48 | 2.81 | 2.84 | |||||
| Days Sales Outstanding TTM | 72.21 | 67.64 | 68.82 | 67.95 | 83.73 | 80.87 | 82.59 | 84.25 | 101.16 | 91.62 | 83.43 | 89.22 | |||||
| Receivables Turnover TTM | 5.05 | 5.40 | 5.30 | 5.37 | 4.36 | 4.51 | 4.42 | 4.33 | 3.61 | 3.98 | 4.37 | 4.09 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -3.13 | -2.93 | -0.48 | -0.26 | -0.55 | -0.44 | -0.05 | 0.25 | 1.33 | 2.05 | 2.91 | 3.50 | |||||
| Free Cash Flow Per Share TTM | 1.26 | 1.24 | 1.40 | 1.05 | 3.45 | 3.34 | 3.00 | 4.69 | 5.70 | 6.67 | 6.51 | 8.44 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | - | - | - | - | - | - | - | 99.73% | 99.60% | 99.51% | 99.43% | |||||
| Operating Profit Margin TTM | -8.74% | -8.01% | -1.44% | -0.62% | -1.65% | -1.25% | -0.00% | 1.11% | 4.04% | 5.58% | 6.75% | 7.52% | |||||
| Net Profit Margin TTM | -9.84% | -9.00% | -1.39% | -0.70% | -1.41% | -1.08% | -0.12% | 0.54% | 2.58% | 3.60% | 4.58% | 5.12% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -20.37% | -21.56% | -22.14% | -24.30% | -29.16% | -33.46% | -35.18% | -35.11% | -32.73% | -28.04% | -20.76% | -5.09% | |||||
| Net Income Growth (1Y) | 456.03% | 551.64% | 788.06% | -198.29% | -138.66% | -120.04% | -101.72% | -93.17% | -70.57% | -61.46% | -54.95% | -42.39% | |||||
| EPS Growth (1Y) | 470.37% | 571.14% | 801.49% | -202.74% | -140.97% | -121.11% | -101.83% | -92.89% | -69.15% | -59.43% | -52.18% | -38.94% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -3.00 | -2.77 | -29.46 | -50.80 | -27.10 | -41.64 | -251.38 | 55.35 | 13.96 | 10.96 | 8.46 | 7.98 | |||||
| P/B TTM | 0.95 | 0.81 | 1.13 | 1.03 | 1.15 | 1.45 | 1.04 | 1.08 | 1.39 | 1.68 | 1.87 | 2.11 | |||||
| P/S TTM | 0.30 | 0.25 | 0.41 | 0.36 | 0.38 | 0.45 | 0.31 | 0.30 | 0.36 | 0.39 | 0.39 | 0.41 | |||||
| Market Cap | 295.82M | 262.51M | 461.84M | 424.02M | 480.68M | 606.16M | 443.74M | 470.01M | 640.52M | 795.98M | 866.51M | 992.66M | |||||
| Enterprise Value | 190.23M | 153.77M | 362.71M | 342.83M | 399.98M | 524.53M | 379.71M | 400.41M | 635.28M | 794.15M | 852.21M | 991.98M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 39.60M | 40.09M | 45.67M | 34.09M | 111.40M | 111.40M | 98.90M | 159.44M | 195.14M | 234.52M | 227.62M | 298.45M | |||||
| Net Debt | -105.58M | -108.74M | -99.13M | -81.19M | -80.70M | -81.63M | -64.02M | -69.60M | -5.24M | -1.83M | -14.30M | -673.00K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
CROSS COUNTRY HEALTHCARE INC (CCRN) — SEC Financial Statements & Analysis
CROSS COUNTRY HEALTHCARE INC (CCRN) is a services-help supply services company, incorporated in DE. CROSS COUNTRY HEALTHCARE INC trades on Nasdaq as: CCRN. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), CROSS COUNTRY HEALTHCARE INC reported a -20.37% year-over-year revenue growth, a Gross Profit Margin of 99.73% (TTM), a Debt-to-Equity ratio of 0.44x, a Price-to-Sales (P/S) ratio of 0.30x (TTM), a Price-to-Book (P/B) ratio of 0.95 (TTM), at a market cap of $295.82M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -20.37%
- Gross Profit Margin TTM
- 99.73%
- Debt To Equity
- 0.44x
- P/S TTM
- 0.30x
- P/B TTM
- 0.95
- Market Cap
- $295.82M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CROSS COUNTRY HEALTHCARE INC in?
CROSS COUNTRY HEALTHCARE INC (CCRN) operates in the Services-Help Supply Services industry.
What is CCRN's market cap?
CROSS COUNTRY HEALTHCARE INC (CCRN) has a market capitalization of $295.82M as of 2026-03-31.
What exchange does CCRN trade on?
CROSS COUNTRY HEALTHCARE INC (CCRN) trades on the Nasdaq.
Where is CROSS COUNTRY HEALTHCARE INC incorporated?
CROSS COUNTRY HEALTHCARE INC is incorporated in DE.